breast cancer SD Flashcards

1
Q

what is the main function of the breast?

A

production and expression of milk
– To provide a nourishment and
immune protection for offspring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does each lobe in the breast contain?

A

Each lobule consists of a variable
number of acini (glands) connecting to
the intralobular duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the role of epithelial cells in the breast?

A

synthesise milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the role of the intralobular duct?

A

connects with the extralobular duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how many lobes do the mammary glands contain?

A

10-20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what happens to the lobes during pregnancy?

A

the lobules undergo controlled proliferation and enlargement in preparation for lactation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what occurs following birth?

A

Following birth hormone fall and it is
prolactin that is necessary for the initiation
of lactation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what happens when breast feeding ceases?

A

When breastfeeding ceases there is a rapid
change to the differentiated lobular
structure, and the breast returns to the
pre-pregnancy structure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how does a breast cancer diagnosis occur?

A

self examination for changes
mammography and ultrasonography
fine-needle aspiration cytology
core biopsy/ vacuum-assisted biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what do benign breast tumours comprise?

A

– Fibroadenomas
– Duct papillomas
– Adenomas
– Connective tissue tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

where do fibrodenomas arise from?

A

the breast lobule, and involve proliferation of both the connective tissue stroma and the glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do you classify breast carcinoma?

A

non- invasive
invasive (infiltrating)
other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the types of non-invasive carcinomas?

A
  • Ductal Carcinoma in Situ (DCIS; Intraductal Carcinoma)
  • Lobular Carcinoma in Situ (LCIS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the types of invasive carcinomas?

A
  • Infiltrating Ductal carcinoma
  • Invasive Lobular Carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do you stage breast cancer tumours?

A

TNM- tumour node metastasis
tumour status and lymph node status
and distant metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the different groups of T4?

A

T4A- tumour has spread into chest wall
T4B- tumour has spread into the skin and the breast wall might be swollen
T4C- spread to both skin and chest wall
T4D- inflammatoru carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are some common sites of metastases?

A

lymph nodes lead to distant sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how can you test for metastases?

A
  • Lymph node ultrasound/Biopsy
  • MRI Scan
  • CT Scan
  • Liver Ultrasound
  • Bone Scan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is stage 0 of breast cancer?

A

Stage 0 is used for ductal carcinoma in situ (DCIS). It is a pre invasive breast cancer. The cancer cells are in breast ducts and have not started to spread into the surrounding breast tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is stage 1 of breast cancer?

A
  • Stage 1 breast cancer means that the cancer is small and only in the breast tissue or it might be found in lymph nodes close to the breast. This is an early stage breast cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is stage 2 of breast cancer?

A
  • Stage 2 breast cancer means that the cancer is either in the breast or in the nearby lymph nodes or both. This is an early stage breast cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is stage 3 of breast cancer?

A
  • Stage 3 means that the cancer has spread from the breast to lymph nodes close to the breast or to the skin of the breast or to the chest wall. This is also called locally advanced breast cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is stage 4 of breast cancer?

A

Stage 4 breast cancer means that the cancer has spread to other parts of
the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

where is ERa expressed?

A

uterus, ovarian cells, Leydig cells in testes,
epididymis, breast, and liver

25
Q

where is ERb highly expressed?

A

prostate epithelium, testes, ovarian granulosa cells, bone marrow, and brain

26
Q

what happens if there is a variation in AF regions?

A

different cofactors will bind

27
Q

do ERa and ERb work the same way?

A

ERα and ERβ have different downstream transcriptional activities, resulting in their
tissue-specific biological actions

28
Q

what bonding occurs with ER agonists such as estradiol?

A

alcohols groups- hydrogen bonds with 3 AA
hydrophobic skeleton- van der waals forces
this causes conformational change= activates receptor

29
Q

what does tamoxifen prevent?

A

ER gene co-activation

30
Q

how does tamoxifen prevent ER gene co-activation?

A

tamoxifen binds to ER
masks the AF2 site
this leads to less co-activator recruitment
partial agonist/antagonist

31
Q

what is tamoxifen?

A

a non steroidal anti-estrogen competitive inhibitor

32
Q

what kind of action do tamoxifen and raloxifen have?

A

both estrogenic AND antiestrogenic actions,
depending on the target tissue.
Strongly antiestrogenic on mammary epithelium
Proestrogenic on uterine epithelium and bone

33
Q

how may tamoxifen resistance occur?

A

– Loss of ER expression in patient
– Activating ER mutations
– ER receptor is hypersensitised to low oestrogen levels
– Increased oestrogen levels – competition
– Altered co-regulators
– Pharmacologic tolerance – increased efflux OR decreased influx of
the drug by membrane pump glycoproteins
– Endocrine adaption and receptor crosstalk (

34
Q

why were aromatase inhibitors used?

A

upon development of resistance of tamoxifen

35
Q

when are aromatase inhibitors used?

A

2nd line treatment in oestrogen dependant breast cancer that have become Tamoxifen resistant

36
Q

what does the aromatase enzyme inhibitor comprised of?

A

– Cytochrome P450 (CYP19A1)
– Reductase enzyme that uses NADH as a cofactor

37
Q

what are the two clinically used aromtase enzyme inhibitors?

A

reversible competitive inhibitor
irreversible inhibitors

38
Q

give an example of a reversible aromatase enzyme inhibitor and how it binds

A

Anastrazole and Letrozole – binds to
haem group of aromatase and prevents
binding to steroid

39
Q

how do irreversible aromatase enzyme inhibitors work?

A
  • More selective that reversible inhibitors
  • Act as “suicide” substrate as they
    permanently inactivate aromatase
    inhibitor
  • Exemestane mimics androstenedione
    but binds irreversibly
  • Overall effect is to lower circulating
    oestrogens
40
Q

what is SERD? how does it work?

A

Brand name Faslodex (Astra Zeneca)
* Selective Estrogen Receptor Degrader (SERD)
* Tightly binds to ER
* Masks both AF1 and AF2 sites
* Causes receptor instability
* ER is then DEGRADED by the proteome

41
Q

what is ER+ve?

A

use drugs that block estrogen producing or estrogen signalling

42
Q

what is HER2 +ve?

A

eg herceptin
use drugs to target HER2 signalling

43
Q

what is triple negative?

A

use other more generalised, more toxic drugs as blocking estrogen/HER2 wont be effective

44
Q

what have mutations that lead to EGFR overexpression been associated with?

A

Adenocarcinoma of the lung (40% of cases),
* Rectal cancers
* Glioblastoma (50%)
* Epithelian tumors of the head and neck (80-100%).

45
Q

what is HER2?

A

HER (Human Epidermal Growth Factor Receptor)
– The HER2 gene amplified in 20-30% of breast cancers
– HER2 is a receptor tyrosine kinase - undergoes dimerization and
autophosphorylation

46
Q

what happens with low HER2 and high HER2?

A

low- normal growth
high=malignant growth

47
Q

what is HER2 amplification/ overexpression associated with?

A

– accelerated cell growth and proliferation
– increased risk of disease recurrence
– shortened overall patient survival.

48
Q

where is HER2 found?

A

Found on the surface of normal breast cells
* Some breast cancer cells have a very high number of HER2 receptors

49
Q

what is trastuzumab?

A

Trastuzumab is a humanized antibody that blocks the HER-2 receptor

50
Q

what monitoring is required with herceptin?

A

– Associated with cardiovascular dysfunction
– Monitoring of cardiac function required

51
Q

what happens to HER2 p95 fragment?

A

HER2 receptor undergoes proteolytic cleavage in overexpressing cells
* Leads to the ECD fragment being shed and an active “p95” domain
* Function not fully characterised
* Associated with poor prognosis for patients

52
Q

how does herceptin illicint an immune response?

A
  • Antibody Dependent Cellular Cytotoxity (ADCC)
  • The Fc domain of Herceptin binds to Natural Killer cells with Fc gamma receptor
  • Herceptin binding not only triggers all previous events but also flags the cells for immune attack
  • Tumour cell lysis occurs
53
Q

what doe herceptin do?

A

Blocks VEGF and Tumour
Vascularisation

54
Q

why does herceptin upregulate?

A

upregulated p27 to block cell cycle

55
Q

how does herceptin resistance occur?

A

Her2 p95 fragment generation
Epitope masking by Mucin
Epitope masking by CD44

56
Q

how does pertuzumab work?

A
  • Binds to HER-2 at a region distinct from trastuzumab (domain II not IV)
  • Overcomes resistance by p95 cleavage and masking
  • UK license for use in combination with docetaxal and trastuzumab
57
Q

who is kadcyla licensed for?

A
  • Licensed for treatment of patients with HER2-positive,
    unresectable, locally advanced or metastatic breast cancer
    – Previously received trastuzumab and a taxane, separately or in
    combination.
58
Q

what should patients starting on kadcyla should have recieved?

A

– Received prior therapy for locally advanced or metastatic disease, or
– Developed disease recurrence during or within six months of
completing adjuvant therapy

59
Q

what effects does herceptin have?

A
  • HER2 binding
  • Prevents dimerization
  • Prevents Her2 ECD
    cleavage p95
  • Blocks down stream
    signalling
  • ADCC